AbbVie’s positive eczema study drags down Regeneron’s shares – Reuters


Reuters
AbbVie's positive eczema study drags down Regeneron's shares
Reuters
AbbVie Inc said on Thursday its experimental drug to treat adults with moderate-to-severe eczema met the main goal in a mid-stage study, dragging down …
AbbVie Inc (ABBV) Stock Surges on Positive Eczema StudyInvestorplace.com
AbbVie shares rally on positive eczema study, competitor Regeneron dropsInvesting.com
AbbVie Scores 2 Wins: 1 Threatens RegeneronMotley Fool
Investor’s Business Daily –Madison.com –Zacks Investment Research
all 145 news articles »

eczema – Google News

Eczema Free Foreverâ„¢